Method For Producing A Freeze-Dried Pharmaceutical Composition Containing Mitomycin C - EP3272361

The patent EP3272361 was granted to Medac Gesellschaft FR Klinische Spezialprparate on Nov 20, 2019. The application was originally filed on Oct 22, 2013 under application number EP17188743A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3272361

MEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATE
Application Number
EP17188743A
Filing Date
Oct 22, 2013
Status
Granted And Under Opposition
Oct 18, 2019
Grant Date
Nov 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOLLATZAug 20, 2020TER MEER STEINMEISTER & PARTNERWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDE19957371
DESCRIPTIONGB830874
DESCRIPTIONUS5216011
OPPOSITIONCN101204382
OPPOSITIONCN1712014
OPPOSITIONEP0782850
OPPOSITIONUS2009162440
OPPOSITIONWO03072082
SEARCHGB2171408
SEARCHUS2009162440

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- WAKAKI et al., Antibiotics and Chemotherapy, (19580000), vol. 8, page 228-
OPPOSITION- Anonymous, "MitosolĀ® Highlights of Prescribing Information", (20120101), pages 1 - 10, XP055800817-
OPPOSITION- Augsburger Larry, Hoag, Stephen, "Rational Design and Formulation. Excerpt", Pharmaceutical dosage forms: Tablets. Third Ed., (20080101), vol. 2, pages 273 - 273, XP055800807-
OPPOSITION- BAHETI A, KUMAR L, BANSAL A K, "Excipients used in lyophilization of small molecules", Journal of Excipients and Food Chemicals, United States, (20100101), vol. 1, no. 1, ISSN 2150-2668, pages 41 - 54, XP002667508-
OPPOSITION- Bianco Carolina L, Et Al, "Effects of Urea on the Microstructure and Phase behavior of Aqueous Solutions of Poly(oxyethylene) Surfactants", Ind. Eng. Chem. Res., (20110101), vol. 50, pages 85 - 96, XP055800801-
OPPOSITION- Jatwani Sandhiya, Et Al, "An overview on solubility enhancement techniques for poorly soluble drugs and solid dispersion as an eminent strategic approach", International Journal of Pharmaceutical Sciences and Research, IN, (20120101), vol. 3, no. 4, ISSN 0975-8232, pages 942 - 956, XP055800822-
OPPOSITION- Kaur Jatinder, Et Al, "Improvement of Drug Solubility Using solid Dispersion", International Journal of Pharmacy and Pharmaceutical Sciences, (20120101), vol. 4, no. 2, pages 47 - 53, XP055800811-
OPPOSITION- OESTERLE et al., "The Influence of Tertiary Butyl Alcohol and Volatile salts on the Sublimation of Ice from Frozen Sucrose Solutions: Implications for Freeze-Drying", Pharm. Dev. Technol., (19980000), pages 175 - 183, XP002103023-
OPPOSITION- MUMENTHALER M , LEUENBERGER H, "ATMOSPHERIC SPRAY-FREEZE DRYING A SUITABLE ALTERNATIVE IN FREEZE-DRYING TECHNOLOGY", INTERNATIONAL JOURNAL OF PHARMACEUTICS, NL, (19910101), vol. 72, no. 2, doi:10.1016/0378-5173(91)90047-R, ISSN 0378-5173, pages 97 - 110, XP002292770

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents